Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Wedelolactone may help treat lung fibrosis by reducing inflammation and lung damage.

Gujian oral liquid reduces osteoarthritis symptoms by targeting inflammation.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

TNF-alpha inhibitors can cause various immune-related skin issues.

Exosome therapy from treated stem cells may help reduce inflammation and promote hair regrowth in alopecia.

High TNF-α levels may increase hair loss risk after PRP therapy.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

AGEs may cause hair loss by increasing inflammation in hair follicles.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

TNF-a may not be as involved in certain types of hair loss as previously thought.

Future acne treatments should aggressively target inflammation to prevent scarring.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.